Member Info for Borsaci06

waiting the data to be published & peer reviewed

or placees may short it to 27

so what will happen when those placing shares hit the market next week

shorts most likely bought on placing

not much here until the Data peer-reviewed

some people run for dry cleaners

RNS Number : 7779T
Physiomics PLC
22 July 2020

" it will be signed in the coming weeks "

do not get cleaned again

RNS Number : 7779T
Physiomics PLC
22 July 2020

" it will be signed in the coming weeks "

do not get cleaned again

what is real spread

Bromhexine 8mg t.i.d. p.o. (typical use) performed extremely well in a recent Iranian RCT, N=78.
https://bi.tbzmed.ac.ir/Files/Inpress/bi-23240.pdf
https://twitter.com/mansarin/status/1285286069827756032

https://uk.investing.com/news/stock-market-news/stockbeat-astrazeneca-philips-synairgen-put-virus-fight-center-stage-2165623

at least one thing we can be sure of that
direct delivery of drug in early stages into infected lungs is approved by almost everyone

this man suggested back in April using NEBULIZER of #remdesivir (10ml*15min/d*5-9 days, need Clin.Trial to test efficacy/safety in 1-2mos)
https://pharmacy.umich.edu/people/duxins

https://twitter.com/C19TrialatHome

Farn up 13% with 71K volume

same dosing 6 MIU SNG001 for both or I am missing something?

COPD https://clinicaltrials.gov/ct2/show/NCT03570359?term=sng001&cond=copd&draw=2&rank=1

COVID 19 https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/inhaled-sng001-in-copd-patients/

there seems a bit of confusion here

" test positive for a virus will be randomised 1:1 to receive 6 MIU SNG001 or placebo once daily for 14 days"

This is from NHS health research authority

https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/inhaled-sng001-in-copd-patients/

can we assume/speculate that
letting friends in or something else

seb24 was guessing a leak
wonder if he found & plugged it

" characterized by no IFN-ß and low IFN-a production and activity "

https://science.sciencemag.org/content/early/2020/07/10/science.abc6027?utm_campaign=SciMag&utm_source=JHubbard&utm_medium=Twitter
https://twitter.com/ScienceMagazine/status/1282677634145583105

is this critical care clinical pharmacist part of pump/dump?

MARY Aurélien
@MARYau_MCU_PH

We could expect better response with IFN beta than alpha, and we could suppose synairgen had also an optimized deposition in lung (but data never published), so we could hope a significant primary outcome.
To note IFN worked in vitro both in prophylaxis and curative way.

Simmo222
he sort of backs you up

MARY Aurélien
@MARYau_MCU_PH
Replying to
@gbelliardo

Oui. Résultats prévus fin juin, décalé à juillet. Ac 6 millions d'euros, aztra derrière. Par contre brevet de composition, là où on fait bisounours ac du matos sans brevet.

Translated from French by

Yes. Results expected end of June, shifted to July. Ac 6 million euros, aztra behind. By cons composition patent, where we make bisounours ac stuff without patent.

meanwhile, Blife is launching clinical trials of AP-003 ( inhalation of INFa2b ).
again using method of direct delivery of interferon to lungs.
their diagram explains early intervention nicely
https://blifetherapeutics.com/

just being cautious

know latest investors, TR1 holders, contracts, potential etc